Three commonly held views appear to hinder millions of Americans with clinical depression or generalized anxiety disorder from being diagnosed or treated, according to the National Mental Health Association's "America's Mental Health Survey."
Three commonly held views appear to hinder millions of Americans with clinical depression or generalized anxiety disorder from being diagnosed or treated, according to the National Mental Health Association's "America's Mental Health Survey."
According to the survey, only 18% of all adult Americans who appear to have met the diagnostic criteria for clinical depression and/or generalized anxiety disorder at some point in their lives have ever received an official diagnosis or treatment. More than 19 million Americans are affected by depression each year, with another four million affected by generalized anxiety disorder, according to the National Institute of Mental Health. The survey findings suggest that the following beliefs account for this gap between prevalence and diagnosis or treatment:
•Â Ninety-three percent of undiagnosed people do not associate their symptoms with a mental health disorder; at the same time, 44% of those undiagnosed say their symptoms cause significant emotional pain and restrict functioning in their daily lives.
•Â Forty-four percent of undiagnosed people unwilling to go to a healthcare professional believe their symptoms are self-manageable; rather than seek professional treatment, many utilize self-help techniques such as prayer (41%), rest (38%), exercise (37%), sleep (31%), or emotional support from family and friends (31%).
•Â Forty-two percent of people with a formal diagnosis say they are embarrassed or ashamed by their symptoms (compared with 17% of those undiagnosed), and twice as many of those with a formal diagnosis (16%, versus 8% of those who are undiagnosed) say they're afraid to talk to their friends about their mental health problems. Further, only two out of five people with a formal diagnosis believe their symptoms mean they have a mental health disorder.
"It's clear that we need to remove the stigma associated with the diagnosis of a mental illness and educate all people about depression and generalized anxiety disorder so they can recognize symptoms and distinguish transient, circumstantial moods or feelings from a more serious mental health problem," said Michael Faenza, president and chief executive officer of the NMHA. "Many people with symptoms of depression or anxiety disorders do not need treatment and can benefit from a range of activities to improve their mental health, such as the basics of communicating, exercising, eating and sleeping right. However, when their feelings persist, worsen or interfere with their daily lives, many people should seek treatment. We must help people recognize when it's time to seek professional help, and then let them know that, with care, their illness can â and should â remit." PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.